Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Titre (en) » - entrée « after »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
africa < after < against  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000008 (2020) J. Prinz [Allemagne] ; Y. D'Hargues [Allemagne] ; P. Gödel [Allemagne] ; A. Shimabukuro-Vornhagen [Allemagne] ; M. Kochanek [Allemagne] ; B. Böll [Allemagne][CARs, CRS and neurotoxicity: severe complications after administration of immunotherapy : Essentials for intensivists].
000046 (2020) Gabriela Sanchez-Petitto [États-Unis] ; Noa G. Holtzman [États-Unis] ; Ali Bukhari [États-Unis] ; Matthew Brown [États-Unis] ; Megan K. Morales [États-Unis] ; Madhurima Koka [États-Unis] ; Jean A. Yared [États-Unis] ; Saurabh Dahiya [États-Unis] ; Aaron P. Rapoport [États-Unis] ; Nancy M. Hardy [États-Unis]Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
000157 (2020) Jingsheng Hua [République populaire de Chine] ; Weiqing Qian [République populaire de Chine] ; Xiaoxia Wu [République populaire de Chine] ; Lili Zhou [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Suning Chen [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Huiying Qiu [République populaire de Chine]Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature
000184 (2020) Maria C. Schneeweiss [États-Unis] ; Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; David Rosmarin [États-Unis] ; Joseph F. Merola [États-Unis]Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa
000208 (2020) Natalia Maximova [Italie] ; Alessandra Maestro [Italie] ; Davide Zanon [Italie] ; Annalisa Marcuzzi [Italie]Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
000219 (2020) Ayako Matsumura [Japon] ; Takuya Miyazaki [Japon] ; Takayoshi Tachibana [Japon] ; Taiki Ando [Japon] ; Megumi Koyama [Japon] ; Satoshi Koyama [Japon] ; Yoshimi Ishii [Japon] ; Hiroyuki Takahashi [Japon] ; Yuki Nakajima [Japon] ; Ayumi Numata [Japon] ; Wataru Yamamoto [Japon] ; Kenji Motohashi [Japon] ; Maki Hagihara [Japon] ; Kenji Matsumoto [Japon] ; Shin Fujisawa [Japon] ; Hideaki Nakajima [Japon]Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study
000278 (2020) Dimitrios A. Pappas [États-Unis] ; Taylor Blachley [États-Unis] ; Steve Zlotnick [États-Unis] ; Jennie Best [États-Unis] ; Kelechi Emeanuru [États-Unis] ; Joel M. Kremer [États-Unis]Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry.
000302 (2020) Adriana Balduzzi [Italie] ; Erica Brivio [Italie, Pays-Bas] ; Attilio Rovelli [Italie] ; Carmelo Rizzari [Italie] ; Serena Gasperini [Italie] ; Maria Luisa Melzi [Italie] ; Valentino Conter [Italie] ; Andrea Biondi [Italie]Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati
000339 (2020) Hsin-Yun Sun [Taïwan] ; Jann-Yuan Wang [Taïwan] ; Yee-Chun Chen [Taïwan] ; Po-Ren Hsueh [Taïwan] ; Yi-Hsuan Chen [Taïwan] ; Yu-Chung Chuang [Taïwan] ; Chi-Tai Fang [Taïwan] ; Shan-Chwen Chang [Taïwan] ; Jung-Der Wang [Taïwan]Impact of introducing fluorescent microscopy on hospital tuberculosis control: A before-after study at a high caseload medical center in Taiwan
000350 (2020) Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel WolffIL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
000384 (2020) M. Cellina [Italie] ; M. Orsi [Italie] ; F. Bombaci [Italie] ; M. Sala [Italie] ; P. Marino [Italie] ; G. Oliva [Italie]Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab.
000432 (2020) Kosuke Ebina [Japon] ; Toru Hirano [Japon] ; Yuichi Maeda [Japon] ; Wataru Yamamoto [Japon] ; Motomu Hashimoto [Japon] ; Koichi Murata [Japon] ; Tohru Takeuchi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Akira Onishi [Japon] ; Sadao Jinno [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Keiichi Yamamoto [Japon] ; Atsushi Kumanogoh [Japon] ; Makoto Hirao [Japon]Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study.
000438 (2020) Boris Fehse [Allemagne] ; Anita Badbaran [Allemagne] ; Carolina Berger [Allemagne] ; Tanja Sonntag [Allemagne] ; Kristoffer Riecken [Allemagne] ; Maria Geffken [Allemagne] ; Nicolaus Kröger [Allemagne] ; Francis A. Ayuk [Allemagne]Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel
000502 (2020) Kazuhisa Nakano [Japon] ; Kazuyoshi Saito [Japon] ; Aya Nawata [Japon] ; Kentaro Hanami [Japon] ; Satoshi Kubo [Japon] ; Ippei Miyagawa [Japon] ; Yoshihisa Fujino [Japon] ; Shingo Nakayamada [Japon] ; Yoshiya Tanaka [Japon]Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
000518 (2020) Kurumi Katsuda [Japon] ; Noriko Arase [Japon] ; Yukinobu Nakagawa [Japon] ; Atsushi Tanemura [Japon] ; Manabu Fujimoto [Japon]Case of granuloma annulare after using tocilizumab.
000595 (2020) Shruti Gupta [États-Unis] ; Harish Seethapathy [États-Unis] ; Ian A. Strohbehn [États-Unis] ; Matthew J. Frigault [États-Unis] ; Elizabeth K. O'Donnell [États-Unis] ; Caron A. Jacobson [États-Unis] ; Shveta S. Motwani [États-Unis] ; Samir M. Parikh [États-Unis] ; Gary C. Curhan [États-Unis] ; Kerry L. Reynolds [États-Unis] ; David E. Leaf [États-Unis] ; Meghan E. Sise [États-Unis]Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma.
000624 (2015) Raja Atreya [Allemagne] ; Ulrike Billmeier [Allemagne] ; Timo Rath [Allemagne] ; Jonas Mudter [Allemagne] ; Michael Vieth [Allemagne] ; Helmut Neumann [Allemagne] ; Markus F. Neurath [Allemagne]First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "after" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "after" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    after
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021